Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version
Identifieur interne : 001635 ( PascalFrancis/Checkpoint ); précédent : 001634; suivant : 001636Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version
Auteurs : Francisco Javier Carod-Artal [Brésil] ; Pablo Martinez-Martin [Espagne] ; Antonio Pedro Vargas [Brésil]Source :
- Movement disorders [ 0885-3185 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
The objective of this study was to perform an independent validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) and assessment of the Parkinson's Disease Questionnaire (PDQ-39), Brazilian version. Patients were evaluated by means of the Unified Parkinson's Disease Rating Scale, Hoehn and Yahr staging (HY), Schwab and England scale, Mini-Mental State Examination, and Hospital Anxiety and Depression Scale. Health-related quality of life was evaluated using the MOS-Short Form 36 (SF-36), PDQ-39, and SCOPA-PS. One hundred forty-four patients were included (mean age, 62 years; 53.5% males; mean duration of illness, 6.6 years; HY, 1-4). Mean SCOPA-PS and PDQ-39 Summary Index (SI) were 39.2 and 40.7, respectively. The internal consistency of SCOPA-PS (Cronbach's alpha = 0.84; item-total correlation, 0.44-0.73) and PDQ-39 dimensions (alpha = 0.61-0.85; item-total correlation, 0.46-0.82) were satisfactory. Concerning the stability of the questionnaires, intraclass correlation coefficient (ICC) values were 0.71 for the SCOPA-PS and 0.86 for the PDQ-39 SI. ICC for PDQ-39 dimensions ranged from 0.52 (social support) to 0.80 (stigma). Standard error of measurement (SEM) values for each PDQ-39 dimension ranged from 0.49 (emotional well-being) to 17.52 (social support). SEM values for SCOPA-PS and PDQ-39 SI were 11.84 and 6.72, respectively. A significant correlation of SCOPA-PS and PDQ-39 SI with the SF-36 physical (-0.42 and -0.52, respectively) and mental components (-0.41) was found. Correlation between SCOPA-PS and PDQ-39 SI was 0.73 (all coefficients, P < 0.0001). The SCOPA-PS and PDQ-39, Brazilian versions, have satisfactory metric attributes.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:07-0133222Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version</title><author><name sortKey="Carod Artal, Francisco Javier" sort="Carod Artal, Francisco Javier" uniqKey="Carod Artal F" first="Francisco Javier" last="Carod-Artal">Francisco Javier Carod-Artal</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Sarah Network of Rehabilitation Hospitals, Sarah Hospital</s1><s2>Brasilia</s2><s3>BRA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Brésil</country><wicri:noRegion>Brasilia</wicri:noRegion></affiliation></author><author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Neuroepidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health</s1><s2>Madrid</s2><s3>ESP</s3><sZ>2 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Pedro Vargas, Antonio" sort="Pedro Vargas, Antonio" uniqKey="Pedro Vargas A" first="Antonio" last="Pedro Vargas">Antonio Pedro Vargas</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Sarah Network of Rehabilitation Hospitals, Sarah Hospital</s1><s2>Brasilia</s2><s3>BRA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Brésil</country><wicri:noRegion>Brasilia</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">07-0133222</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 07-0133222 INIST</idno><idno type="RBID">Pascal:07-0133222</idno><idno type="wicri:Area/PascalFrancis/Corpus">001830</idno><idno type="wicri:Area/PascalFrancis/Curation">001491</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001635</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version</title><author><name sortKey="Carod Artal, Francisco Javier" sort="Carod Artal, Francisco Javier" uniqKey="Carod Artal F" first="Francisco Javier" last="Carod-Artal">Francisco Javier Carod-Artal</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Sarah Network of Rehabilitation Hospitals, Sarah Hospital</s1><s2>Brasilia</s2><s3>BRA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Brésil</country><wicri:noRegion>Brasilia</wicri:noRegion></affiliation></author><author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Neuroepidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health</s1><s2>Madrid</s2><s3>ESP</s3><sZ>2 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Pedro Vargas, Antonio" sort="Pedro Vargas, Antonio" uniqKey="Pedro Vargas A" first="Antonio" last="Pedro Vargas">Antonio Pedro Vargas</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Sarah Network of Rehabilitation Hospitals, Sarah Hospital</s1><s2>Brasilia</s2><s3>BRA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Brésil</country><wicri:noRegion>Brasilia</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Nervous system diseases</term><term>Parkinson disease</term><term>Quality of life</term><term>Validation</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term><term>Parkinson maladie</term><term>Validation</term><term>Qualité vie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to perform an independent validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) and assessment of the Parkinson's Disease Questionnaire (PDQ-39), Brazilian version. Patients were evaluated by means of the Unified Parkinson's Disease Rating Scale, Hoehn and Yahr staging (HY), Schwab and England scale, Mini-Mental State Examination, and Hospital Anxiety and Depression Scale. Health-related quality of life was evaluated using the MOS-Short Form 36 (SF-36), PDQ-39, and SCOPA-PS. One hundred forty-four patients were included (mean age, 62 years; 53.5% males; mean duration of illness, 6.6 years; HY, 1-4). Mean SCOPA-PS and PDQ-39 Summary Index (SI) were 39.2 and 40.7, respectively. The internal consistency of SCOPA-PS (Cronbach's alpha = 0.84; item-total correlation, 0.44-0.73) and PDQ-39 dimensions (alpha = 0.61-0.85; item-total correlation, 0.46-0.82) were satisfactory. Concerning the stability of the questionnaires, intraclass correlation coefficient (ICC) values were 0.71 for the SCOPA-PS and 0.86 for the PDQ-39 SI. ICC for PDQ-39 dimensions ranged from 0.52 (social support) to 0.80 (stigma). Standard error of measurement (SEM) values for each PDQ-39 dimension ranged from 0.49 (emotional well-being) to 17.52 (social support). SEM values for SCOPA-PS and PDQ-39 SI were 11.84 and 6.72, respectively. A significant correlation of SCOPA-PS and PDQ-39 SI with the SF-36 physical (-0.42 and -0.52, respectively) and mental components (-0.41) was found. Correlation between SCOPA-PS and PDQ-39 SI was 0.73 (all coefficients, P < 0.0001). The SCOPA-PS and PDQ-39, Brazilian versions, have satisfactory metric attributes.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>22</s2></fA05><fA06><s2>1</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version</s1></fA08><fA11 i1="01" i2="1"><s1>CAROD-ARTAL (Francisco Javier)</s1></fA11><fA11 i1="02" i2="1"><s1>MARTINEZ-MARTIN (Pablo)</s1></fA11><fA11 i1="03" i2="1"><s1>PEDRO VARGAS (Antonio)</s1></fA11><fA14 i1="01"><s1>Department of Neurology, Sarah Network of Rehabilitation Hospitals, Sarah Hospital</s1><s2>Brasilia</s2><s3>BRA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></fA14><fA14 i1="02"><s1>Neuroepidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health</s1><s2>Madrid</s2><s3>ESP</s3><sZ>2 aut.</sZ></fA14><fA20><s1>91-98</s1></fA20><fA21><s1>2007</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000145483830130</s5></fA43><fA44><s0>0000</s0><s1>© 2007 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>52 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>07-0133222</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>The objective of this study was to perform an independent validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) and assessment of the Parkinson's Disease Questionnaire (PDQ-39), Brazilian version. Patients were evaluated by means of the Unified Parkinson's Disease Rating Scale, Hoehn and Yahr staging (HY), Schwab and England scale, Mini-Mental State Examination, and Hospital Anxiety and Depression Scale. Health-related quality of life was evaluated using the MOS-Short Form 36 (SF-36), PDQ-39, and SCOPA-PS. One hundred forty-four patients were included (mean age, 62 years; 53.5% males; mean duration of illness, 6.6 years; HY, 1-4). Mean SCOPA-PS and PDQ-39 Summary Index (SI) were 39.2 and 40.7, respectively. The internal consistency of SCOPA-PS (Cronbach's alpha = 0.84; item-total correlation, 0.44-0.73) and PDQ-39 dimensions (alpha = 0.61-0.85; item-total correlation, 0.46-0.82) were satisfactory. Concerning the stability of the questionnaires, intraclass correlation coefficient (ICC) values were 0.71 for the SCOPA-PS and 0.86 for the PDQ-39 SI. ICC for PDQ-39 dimensions ranged from 0.52 (social support) to 0.80 (stigma). Standard error of measurement (SEM) values for each PDQ-39 dimension ranged from 0.49 (emotional well-being) to 17.52 (social support). SEM values for SCOPA-PS and PDQ-39 SI were 11.84 and 6.72, respectively. A significant correlation of SCOPA-PS and PDQ-39 SI with the SF-36 physical (-0.42 and -0.52, respectively) and mental components (-0.41) was found. Correlation between SCOPA-PS and PDQ-39 SI was 0.73 (all coefficients, P < 0.0001). The SCOPA-PS and PDQ-39, Brazilian versions, have satisfactory metric attributes.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B02B05</s0></fC02><fC02 i1="03" i2="X"><s0>002B15F</s0></fC02><fC02 i1="04" i2="X"><s0>002B18D04B</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Validation</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Validation</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Validación</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Qualité vie</s0><s5>10</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Quality of life</s0><s5>10</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Calidad vida</s0><s5>10</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>40</s5></fC07><fN21><s1>085</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>Brésil</li><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><country name="Brésil"><noRegion><name sortKey="Carod Artal, Francisco Javier" sort="Carod Artal, Francisco Javier" uniqKey="Carod Artal F" first="Francisco Javier" last="Carod-Artal">Francisco Javier Carod-Artal</name></noRegion><name sortKey="Pedro Vargas, Antonio" sort="Pedro Vargas, Antonio" uniqKey="Pedro Vargas A" first="Antonio" last="Pedro Vargas">Antonio Pedro Vargas</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001635 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001635 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:07-0133222
|texte= Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version
}}
| This area was generated with Dilib version V0.6.23. |  |